Mark F van Delft

11PUBLICATIONS
60CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 09, 2026
The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

|Sep 02, 2026
MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

|Apr 09, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Jia-Nan Gong, Tirta M Djajawi, Donia M Moujalled

|Mar 05, 2025
Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.

Kaiming Li, Yu Q Yap, Donia M Moujalled

|Sep 28, 2022
Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteins.

Allan Shuai Huang, Hui San Chin, Boris Reljic

|Apr 02, 2022
The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.

Annette V Jacobsen, Catia L Pierotti, Kym N Lowes

Pageof 2

Frequent Collaborators

7 joint publications

David Ching Siang Huang

5 joint publications

Guillaume Lessene

3 joint publications

Andrew W Roberts

3 joint publications

Laura F Dagley